COVID-19 Drives Demand for Active Pharmaceutical Ingredients (APIs) in North America

COVID-19 Drives Demand for Active Pharmaceutical Ingredients (APIs) in North America

COVID-19 Drives Demand for Active Pharmaceutical Ingredients (APIs) in North America


Attachment: API pharma 0421, PHARMA API

SUGAR LAND--April 29, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--Pharmaceuticals and biological drugs are manufactured using ingredients usually produced offsite. Historically, the U.S. and Canada have relied heavily on countries such as China, India and Italy to supply these ingredients in a timely and economic manner. But the pandemic fueled a need to produce active pharmaceutical ingredients (APIs) domestically to secure supply chains for North American drug manufacturers.

Subscribe Now!(All Fields Required)

Standard Membership - Free